Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
atopic dermatitis
Biotech
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
The French drugmaker removed Ablynx and Principia Biopharma molecules from its pipeline after getting a look at clinical data.
Nick Paul Taylor
Apr 27, 2023 7:41am
Another Flagship biotech focused on the microbiome struggles
Apr 26, 2023 10:45am
Minghui's phase 2 win for potential Opzelura competitor
Apr 14, 2023 10:35am
BenevolentAI flunks midphase eczema trial to dent deal plans
Apr 5, 2023 7:00am
Corvus pauses plans to start eczema trial to focus on cancer
Mar 29, 2023 9:55am
Vyne swings behind BET, seeks partner for failed eczema drug
Mar 10, 2023 9:30am
